Kinex Pharmaceuticals Garners $74,399,996 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7b962338-964b-4f9d-a3ef-8f8a2f99d183 - Date
6/16/2015 - Company Name
Kinex Pharmaceuticals - Mailing Address
701 Ellicott Street Buffalo, NY 14203 USA - Company Description
Kinex is a specialty pharmaceutical company focused on the development and commercialization of next generation therapies for cancer and immunomodulatory diseases. - Website
http://www.kinexpharma.com - Transaction Type
Venture Equity - Transaction Amount
$74,399,996 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
